Riskpilot← Back to searchSign inGet full accessBeact Medica AB
ABDissolvedOrg 5567272348Erikslustvägen 22General medical practice activities · NACE 8621Est. 20070 employees
Revenue 2025
SEK 3M
-17% vs 2024
EBITDA margin
-4.2%
-122% vs 2024
Equity ratio
17.8%
Financial strength
Net profit 2025
SEK -155K
-139% vs 2024
| Revenue | SEK 3M | -17% |
| EBITDA | SEK -123K | -122% |
| Net profit | SEK -155K | -139% |
| Total assets | SEK 535K | -57% |
| Equity | SEK 95K | -84% |
| Employees | 0 | — |
Legal name
Beact Medica AB
Org number
5567272348
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 mars 2007
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva läkarkonsultverksamhet och hälsofrämjande aktiviteter inklusive fritidsaktiviteter inom och utanför Sverige samt därmed förenlig verksamhet.
Address
Erikslustvägen 22
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 750 | 3 697 | 3 970 | 3 590 | 2 968 |
| Staff expenses | — | — | — | −1 537 | −2 024 |
| EBITDA | 716 | 444 | 555 | 569 | −123 |
| Depreciation & amort. | −75 | −102 | −152 | −66 | −34 |
| EBIT | 641 | 342 | 403 | 503 | −157 |
| Net financials | — | −2 | −1 | 3 | 3 |
| Profit before tax | 673 | 369 | 402 | 506 | −155 |
| Tax | −146 | −78 | −88 | −107 | — |
| Net profit | 527 | 291 | 314 | 399 | −155 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 731 | 2 072 | 1 784 | 1 231 | 535 |
| Equity | 641 | 433 | 747 | 596 | 95 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 1 060 | 1 640 | 1 038 | 635 | 440 |
| Total debt | 1 060 | 1 640 | 1 038 | 635 | 440 |
EBITDA margin
-4.2%
This company
15.8%
Market median
-127% vs market
20212025
Equity ratio
17.8%
This company
38.2%
Market median
-53% vs market
20212025
Return on equity
-162.1%
This company
18.4%
Market median
-981% vs market
20212025
Net profit margin
-5.2%
This company
8.1%
Market median
-164% vs market
20212025
Asset turnover
5.54×
This company
1.12×
Market median
+395% vs market
20212025
Debt / equity
4.61×
This company
0.62×
Market median
-644% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EC | Audit | 2022 |
KA Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
MB Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Beact Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Christina Kallin Sharpe | Audit | 0 companies |
| Marius Begu | Chief Executive Officer | 0 companies |
| Karl Agner Heby Kristensen | Chief Executive Officer | 0 companies |
| Vind Ludwigs René | Board of Directors | 0 companies |
| Raluca-Maria Berggren | Deputy Board Member | 0 companies |